Brief Report: Tivantinib in Combination with Erlotinib Versus Erlotinib Alone for EGFR Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study.
| Image |  |
|---|---|
| Description | scientific article published on 27 December 2017 |
| Author/s |
author: Sergey Orlov Brian Schwartz |
| Publication date | December 27, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |